{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:09:40Z","timestamp":1765483780369},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T00:00:00Z","timestamp":1271376000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T00:00:00Z","timestamp":1271376000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1111\/j.1365-2133.2010.09812.x","type":"journal-article","created":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T15:52:24Z","timestamp":1271433144000},"page":"564-571","source":"Crossref","is-referenced-by-count":10,"title":["Malignant T cells in cutaneous T-cell lymphoma lesions contain decreased levels of the antiapoptotic protein Ku70"],"prefix":"10.1093","volume":"163","author":[{"given":"K.","family":"Ferenczi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ohtola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.K.","family":"Somani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Gilliam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.Z.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.S.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,4,16]]},"reference":[{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB1|cit1","first-page":"85","volume-title":"American Cancer Society Atlas of Clinical Oncology: Skin Cancer","author":"Ferenczi","year":"2000"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","article-title":"Increased CCR4 expression in cutaneous T cell lymphoma","volume":"119","author":"Ferenczi","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1749-6632.2001.tb03723.x","article-title":"Apoptosis and cutaneous T cell lymphoma","volume":"941","author":"Kacinski","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.2001.tb03710.x","article-title":"Reversible resistance to apoptosis in cutaneous T cell lymphoma","volume":"941","author":"Meech","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-2133.2001.04523.x","article-title":"Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis","volume":"145","author":"Nevala","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1523-1747.2002.01794.x","article-title":"Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin","volume":"118","author":"Dereure","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000080999","article-title":"Fas gene mutations in mycosis fungoides: analysis of laser capture-microdissected specimens from cutaneous lesions","volume":"67","author":"Nagasawa","year":"2004","journal-title":"Oncology"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB9|cit9","first-page":"5389","article-title":"A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma","volume":"62","author":"Van Doorn","year":"2002","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/jid.2008.309","article-title":"Low FAS\/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation","volume":"129","author":"Wu","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.leu.2402093","article-title":"Constitutive STAT3-activation in S\u00e9zary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic S\u00e9zary cells","volume":"15","author":"Eriksen","year":"2001","journal-title":"Leukemia"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.leu.2403385","article-title":"In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3","volume":"18","author":"Sommer","year":"2004","journal-title":"Leukemia"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0560.1995.tb00733.x","article-title":"Expression of bcl-2 protein and Ki-67 nuclear proliferation antigen in benign and malignant cutaneous T-cell infiltrates","volume":"22","author":"Dummer","year":"1995","journal-title":"J Cutan Pathol"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2141.1999.01773.x","article-title":"Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients","volume":"107","author":"Bladon","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/archderm.141.3.315","article-title":"Biological effects of bexarotene in cutaneous T-cell lymphoma","volume":"141","author":"Budgin","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1523-1747.1998.00278.x","article-title":"Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders","volume":"111","author":"Fox","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1751-1097.1996.tb05657.x","article-title":"PUVA treatment selectively induces a cell cycle block and subsequent apoptosis in human T-lymphocytes","volume":"63","author":"Johnson","year":"1996","journal-title":"Photochem Photobiol"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/1523-1747.ep12329711","article-title":"Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell lymphoma: relevance to mechanism of therapeutic action","volume":"107","author":"Yoo","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB19|cit19","first-page":"1234","article-title":"Induction of apoptosis by bexarotene in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action","volume":"8","author":"Zhang","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.0022-202X.2005.23925.x","article-title":"Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action","volume":"125","author":"Zhang","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1097-2765(04)00094-2","article-title":"Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis","volume":"13","author":"Cohen","year":"2004","journal-title":"Mol Cell"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1073\/pnas.0408351102","article-title":"Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0921-8777(99)00006-3","article-title":"Ku, a DNA repair protein with multiple cellular functions?","volume":"434","author":"Featherstone","year":"1999","journal-title":"Mutat Res"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1073\/pnas.96.4.1403","article-title":"Catalytic subunit of DNA-dependent protein kinase: impact on lymphocyte development and tumorigenesis","volume":"96","author":"Kurimasa","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ncb950","article-title":"Ku70 suppresses the apoptotic translocation of Bax to mitochondria","volume":"5","author":"Sawada","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ncb955","article-title":"Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70","volume":"5","author":"Sawada","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1097-2765(00)80108-2","article-title":"Ku70: a candidate tumor suppressor gene for murine T cell lymphoma","volume":"2","author":"Li","year":"1998","journal-title":"Mol Cell"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1471-4159.2001.00380.x","article-title":"Role of DNA-dependent protein kinase in neuronal survival","volume":"78","author":"Chechlacz","year":"2001","journal-title":"J Neurochem"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and S\u00e9zary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jmb.2004.01.057","article-title":"The membrane-associated form of the DNA repair protein Ku is involved in cell adhesion to fibronectin","volume":"337","author":"Monferran","year":"2004","journal-title":"J Mol Biol"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/sj.emboj.7600403","article-title":"The membrane form of the DNA repair protein Ku interacts at the cell surface with metalloproteinase 9","volume":"23","author":"Monferran","year":"2004","journal-title":"EMBO J"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB32|cit32","first-page":"4012","article-title":"Ku autoantigen affects the susceptibility to anticancer drugs","volume":"59","author":"Kim","year":"1999","journal-title":"Cancer Res"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.yexcr.2005.11.016","article-title":"Involvement of the ubiquitin pathway in decreasing Ku70 levels in response to drug-induced apoptosis","volume":"312","author":"Gama","year":"2006","journal-title":"Exp Cell Res"},{"key":"10.1111\/j.1365-2133.2010.09812.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.1158\/0008-5472.CAN-06-3996","article-title":"Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation","volume":"67","author":"Chen","year":"2007","journal-title":"Cancer Res"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.09812.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.09812.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2010.09812.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:48:51Z","timestamp":1676382531000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/163\/3\/564\/6642737"}},"subtitle":["Decreased Ku70 in CTCL"],"short-title":[],"issued":{"date-parts":[[2010,4,16]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09812.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4,16]]}}}